BioMarin Pharmaceutical Inc. (BVMF:B1MR34)
Brazil · Delayed Price · Currency is BRL 169.17
-2.76 (-1.61%)
At close: Dec 23, 2025
BioMarin Pharmaceutical Market Cap
BioMarin Pharmaceutical has a market cap or net worth of 63.8 billion as of December 24, 2025. Its market cap has decreased by -17.23% in one year.
Market Cap
63.80B
Enterprise Value
58.98B
Revenue
16.49B
Ranking
n/a
PE Ratio
23.01
Stock Price
169.17
Market Cap Chart
Since July 23, 1999, BioMarin Pharmaceutical's market cap has increased from 813.63M to 63.80B, an increase of 7,742.03%. That is a compound annual growth rate of 17.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2025 | 65.12B | -15.95% |
| Dec 31, 2024 | 77.48B | -12.09% |
| Dec 29, 2023 | 88.13B | -13.33% |
| Dec 30, 2022 | 101.68B | 12.51% |
| Dec 31, 2021 | 90.38B | 9.32% |
| Dec 31, 2020 | 82.67B | 35.42% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rede D'Or São Luiz | 91.95B |
| Raia Drogasil | 40.06B |
| Hypera | 14.67B |
| Fleury | 8.18B |
| Odontoprev | 6.07B |
| Diagnósticos da América | 5.45B |
| Empreendimentos Pague Menos | 4.01B |
| Oncoclínicas do Brasil Serviços Médicos | 2.92B |